Figure 2.
Rationalized design of the proposed new pro-apoptotic agents (Series-I-to-III), relying on the pan Bcl-2 inhibitor, obatoclax.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.